Showing results (401-410 of 921) with videos related to

Sort By:
Pageof 93
Biomolecular NMR Assignments|January 26, 2019
NMR chemical shift assignment of the C-terminal region of the Menangle virus phosphoproteinN Herr, M N Webby, E M M Bulloch, et al.
Cancer Chemotherapy and Pharmacology|August 13, 2002
Phase I/II trial of weekly epidoxorubicin and docetaxel (wED) in the neoadjuvant and palliative treatment of patients with breast cancerCatharina Wenzel, Gottfried J Locker, Ursula Pluschnig, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2000
TP53 mutation and p53 overexpression for prediction of response to neoadjuvant treatment in breast cancer patientsD Kandioler-Eckersberger, C Ludwig, M Rudas, et al.
Breast Cancer Research and Treatment|October 25, 2006
Invasive ductal carcinoma and invasive lobular carcinoma of breast differ in response following neoadjuvant therapy with epidoxorubicin and docetaxel + G-CSFCatharina Wenzel, Rupert Bartsch, Dagmar Hussian, et al.
European Journal of Cancer (Oxford, England : 1990)|October 19, 2005
Fulvestrant ('Faslodex') in pre-treated patients with advanced breast cancer: a single-centre experienceG G Steger, R Bartsch, C Wenzel, et al.
Cancer Research|July 1, 1997
5-fluorouracil kinetics in the interstitial tumor space: clinical response in breast cancer patientsM Müller, R M Mader, B Steiner, et al.
Endocrine-Related Cancer|March 26, 2003
Sequential steroid hormone receptor measurements in primary breast cancer with and without intervening primary chemotherapyS Taucher, M Rudas, M Gnant, et al.
Cancer Immunology, Immunotherapy : CII|September 22, 2000
Sequential administration of interferon gamma and interleukin-2 in metastatic renal cell carcinoma: results of a phase II trial. Austrian Renal Cell Carcinoma Study GroupM Schmidinger, G G Steger, C Wenzel, et al.
Diabetes, Nutrition & Metabolism|April 27, 2000
Effects of acarbose treatment in Type 2 diabetic patients under dietary training: a multicentre, double-blind, placebo-controlled, 2-year studyH Hasche, G Mertes, C Bruns, et al.
Wiener Klinische Wochenschrift|September 29, 2000
Glutathione in the prevention of cisplatin induced toxicities. A prospectively randomized pilot trial in patients with head and neck cancer and non small cell lung cancerM Schmidinger, A C Budinsky, C Wenzel, et al.
Pageof 93